Skip to content

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01699867
Enrollment
50
Registered
2012-10-04
Start date
2012-12-31
Completion date
2014-04-30
Last updated
2015-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

lumpectomy, breast cancer, optical coherence tomography, tumor margin, imaging

Brief summary

This multi-center, prospective, open label study analyzed specimens from fifty subjects at two study sites. Patients scheduled to undergo breast-conserving surgery were recruited in accordance with the inclusion and exclusion criteria. The study period per subject was the time it took to assess the ex vivo breast tissue sample using the study device. Image review was conducted after surgery and compared to the margin status findings in the post-operative pathology report.

Interventions

DEVICEOptical coherence tomography

Optical coherence tomography was used to image ex vivo breast tissue specimens.

Sponsors

Johns Hopkins University
CollaboratorOTHER
Diagnostic Photonics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Women 18 years of age or older 2. Signed informed consent form 3. Women who have been histologically diagnosed with carcinoma of the breast prior to surgery 4. Patients planning breast preservation and undergoing lumpectomy (partial mastectomy) procedure

Exclusion criteria

1. Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast) 2. Neoadjuvant systemic therapy 3. All T4 tumors 4. Previous radiation in the operated breast 5. Prior surgical procedure in the same quadrant 6. Implants in the operated breast 7. Pregnancy 8. Lactation 9. Participating in any other investigational study for either drug or device which can influence collection of valid data under this study

Design outcomes

Primary

MeasureTime frameDescription
Patients With All Positive Margins Correctly Identified With the Deviceone week after surgeryIn this study, a patient had positive margins if tumor was identified at the true margin (i.e., the final margin or new margin) surface of at least one specimen by histology (0 mm, tumor on ink).
Number of Margins With False Positive Device Readingsone week after surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Optical Coherence Tomography (Single-arm)
Specimens from all patients were evaluated by optical coherence tomography.
46
Total46

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyScreening Failure3

Baseline characteristics

CharacteristicOptical Coherence Tomography (Single-arm)
Age, Continuous62 years
Sex: Female, Male
Female
46 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 47
serious
Total, serious adverse events
0 / 47

Outcome results

Primary

Number of Margins With False Positive Device Readings

Time frame: one week after surgery

Population: Patients with all negative margins (≥ 2 mm). On average, 5 out of 6 possible margins were analyzed per patient.

ArmMeasureValue (MEAN)Dispersion
Optical Coherence Tomography (Single-arm)Number of Margins With False Positive Device Readings1.32 False positive margins per patientStandard Deviation 1.38
Primary

Patients With All Positive Margins Correctly Identified With the Device

In this study, a patient had positive margins if tumor was identified at the true margin (i.e., the final margin or new margin) surface of at least one specimen by histology (0 mm, tumor on ink).

Time frame: one week after surgery

Population: Patients with positive margins (0 mm, tumor on ink).

ArmMeasureValue (NUMBER)
Optical Coherence Tomography (Single-arm)Patients With All Positive Margins Correctly Identified With the Device5 Patients w/ all positives identified

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026